How dopamine switches on movement neurons (and what breaks in Parkinson's)

Imagine your brain as a city full of light switches. Every time you want to move, a special type of neuron turns on to start the action. But what happens when these switches don't work properly? New research has discovered a key mechanism that could explain a lot about movement disorders like Parkinson's.

The neurons that make us move are called medium spiny neurons (MSNs) and they live in a brain region called the striatum. Their functioning depends on two main elements: dopamine, a neurotransmitter, and a specific potassium channel called Kir.

Until now, scientists didn't fully understand how dopamine regulated these potassium channels. Some studies said one thing, others said the opposite. Now researchers have found the answer: dopamine, through D1 receptors, inhibits the Kir channel. This means it blocks potassium from leaving the neuron, making the cell more excitable and more likely to generate an electrical signal.

The result? When dopamine activates D1 receptors, movement neurons become more active and we move.

But there's a fascinating detail. In mice with a Parkinson's model (where dopamine is reduced), dopamine's effect on neurons is actually stronger. As if the brain tries to compensate for the lack of dopamine by amplifying the response of the few remaining receptors.

When researchers blocked the Kir channel with barium chloride, the parkinsonian mice started moving more. This demonstrates that the potassium channel is indeed the crucial point where dopamine acts to control movement.

This is an important discovery: understanding this mechanism could help develop new strategies to treat movement disorders.

Kir channels (inwardly rectifying potassium channels) represent a family of membrane proteins that allow selective passage of potassium ions across the cell membrane. Their distinguishing feature is 'inward rectification', meaning they conduct potassium current better inward than outward. This property is crucial for maintaining neuron resting potential close to potassium equilibrium potential (approximately -90 mV).

In the striatum, MSNs express different subtypes of Kir channels, including Kir2.x and Kir3.x. Kir2 channels are responsible for basal hyperpolarization, while Kir3 channels are modulated by G-protein coupled receptors (GPCRs), such as dopamine receptors.

The discovered molecular mechanism involves D1R activation (Gs-coupled receptors) increasing cAMP levels and activating protein kinase A (PKA). PKA directly phosphorylates Kir3 channels, reducing their conductance. This effect is particularly pronounced in direct pathway MSNs (D1-MSNs), which express high levels of D1R and form the 'movement-promoting' pathway of the basal ganglia.

The occlusion of dopamine's effect by BaCl2 confirms that Kir inhibition is the main mechanism through which dopamine increases D1-MSN excitability. Surprisingly, this effect is enhanced in dopamine-depleted striatum, suggesting compensatory upregulation of D1R downstream signaling mechanisms or increased Kir channel expression under dopaminergic depletion conditions.

This discovery has therapeutic implications: specific pharmacological targeting of striatal Kir channels could offer an alternative or complementary approach to traditional dopaminergic therapy in Parkinson's, avoiding some side effects associated with systemic dopamine receptor activation.